Clinical trials: Closed-Loop Glucose Control
Type 1 Diabetes
Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)
Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications.
- Trial name
- TightT1AHCL (NCT06466967)
- Testing
- Advanced hybrid closed-loop CamAPS FX
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Castilla-La Mancha Health Service
Type 1 Diabetes Mellitus
Physiologic Response to Glucagon at Varying Insulin Levels
The purpose of this research study is to test how different levels of insulin block the effect of glucagon. Insulin is a hormone that lowers blood glucose. Glucagon raises blood glucose.
- Trial name
- NCT01483651
- Testing
- Glucagon, Insulin
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Legacy Health System
Type 1 Diabetes
Feasibility and Safety Study of the Automated Insulin Delivery Closed Loop System Pancreas4ALL
Pilot prospective controlled monocentric open-label, randomized study evaluating the feasibility and safety of the Pancreas4All automated "closed loop" glycemic control system.
- Trial name
- ASAP (NCT04835350)
- Testing
- Pancreas4ALL - meal announcement or full closed loop
- Where
- Czechia
- Volunteers
- 16 people
- Sponsor
- Lenka Petruzelkova
Diabetes Mellitus, Type 1
Biosensors for Open and Closed-loop Glycemia Control in T1D Patients With Insulin Pump
In T1D, the destruction of beta-pancreatic cells causes insulin deficiency and requires insulin therapy whose control remains complex: even with recent technologies of continuous measurement and monitoring of blood glucose (CGM)…
- Trial name
- DIABLO (NCT04081883)
- Testing
- Biosensor algorithm
- Where
- France
- Volunteers
- 1 people
- Sponsor
- University Hospital, Bordeaux
Type 1 Diabetes
Closed Loop Insulin Therapy in Type 1 Diabetics Based on Blood Microdialysis, Online Sensors and an eMPC Algorithm
The EU funded project CLINICIP (Closed Loop Insulin Infusion for Critically Ill Patients) aims to develop a low-risk monitoring and control device which allows maintaining metabolic control in intensive care units.
- Trial name
- NCT00535483
- Where
- Austria
- Volunteers
- 4 people
- Sponsor
- Medical University of Graz
Type 1 Diabetes
Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
The study seeks to evaluate a novel treatment approach for performing continuous real-time glucose sensing and insulin delivery at the same subcutaneous tissue site.
- Trial name
- NCT02359617
- Testing
- insulin delivery, glucose sensing
- Where
- Austria
- Volunteers
- 10 people
- Sponsor
- Medical University of Graz
Type 1 Diabetes
Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity.
The main objective is to assess if the Diabeloop algorithm provides better glycemic control than a "manual" usual algorithm of patients with type 1 diabetes treated by insulin pump during meals, and during activity qualified…
- Trial name
- DiabeloopWP6-0 (NCT01754181)
- Testing
- Insulin
- Where
- 3 sites in France
- Volunteers
- 18 people
- Sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Type 1 Diabetes
DiaCon Overnight Closed-Loop Glucose Control Study
The objective of this in-clinic study is to test our closed-loop glucose control system in patients with type 1 diabetes.
- Trial name
- DiaCon2 (NCT01444443)
- Testing
- Closed-loop control, Open-loop control
- Where
- Denmark
- Volunteers
- 12 people
- Sponsor
- Hvidovre University Hospital
Type 1 Diabetes
Simple Meal Management Using Automated Insulin Delivery System
Carbohydrate counting is an essential component of diabetes management in both adults and children, and together with an intensive insulin plan and increased blood glucose monitoring was associated with lower HbA1c.
- Trial name
- SMMAID (NCT06130215)
- Testing
- Simple meal management, Precise meal management
- Where
- Qatar
- Volunteers
- 34 people
- Sponsor
- Sidra Medicine
Type 1 Diabetes
Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling
The investigators are doing this research study to compare the pharmacokinetics (PK) (rate of absorption) of insulin lispro (Humalog), insulin aspart (Novolog), and insulin glulisine (Apidra) within individual subjects.
- Trial name
- NCT01684943
- Testing
- Multiplex pharmacokinetic profiling, Continuous insulin monitoring
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Massachusetts General Hospital
Type 1 Diabetes
Two Way Crossover Closed Loop MPC vs Control IQ
An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system.
- Trial name
- NCT05799781
- Testing
- MPC closed-loop system, t:slim X2 pump with Dexcom G6 CGM and Control IQ
- Where
- 2 sites in United States
- Volunteers
- 29 people
- Sponsor
- Oregon Health and Science University
Diabetes Mellitus, Type I
Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)
The objective of this study is to evaluate glycemic control of users of the AHCL system MiniMed 780G with GS4 calibration-free sensor in children and adolescents with newly diagnosed T1D implemented directly upon T1D diagnosis in…
- Trial name
- NCT06919029
- Testing
- Advanced Hybrid Closed Loop from onset of type 1 diabetes in children
- Where
- Greece
- Volunteers
- 30 people
- Sponsor
- National and Kapodistrian University of Athens
Type 1 Diabetes
Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
This is a randomized prospective single blind trial to evaluate blood glucose control overnight under closed-loop insulin delivery with MD-Logic Artificial Pancreas (MDLAP) system in patients with type 1 diabetes, being conducted…
- Trial name
- NCT01726829
- Testing
- MD-Logic Artificial Pancreas (MDLAP) system, sensor augmented pump therapy
- Where
- 3 sites in Germany, Israel and 1 more
- Volunteers
- 75 people
- Sponsor
- Rabin Medical Center